No Data
Sanofi Starts Bidding Process to Sell Consumer Health Division, Bloomberg Reports
-- Sanofi is seeking buyers for its consumer health arm as it simultaneously plans to potentially list the unit, Bloomberg reported, citing unnamed sources. -- The French pharmaceutical giant set a m
Vigil: Program Includes Clinical Candidate VG-3927, Being Evaluated in Phase 1 Study for Alzheimer's >VIGL
Vigil: Program Includes Clinical Candidate VG-3927, Being Evaluated in Phase 1 Study for Alzheimer's >VIGL
Vigil Neuroscience Is a Clinical-Stage Biotechnology Company >VIGL
Vigil Neuroscience Is a Clinical-Stage Biotechnology Company >VIGL
Vigil Expects Proceeds to Extend Cash Runway Into 2026 >VIGL
Vigil Expects Proceeds to Extend Cash Runway Into 2026 >VIGL
Vigil: Will Use Proceeds to Fund R&D Activities >VIGL
Vigil: Will Use Proceeds to Fund R&D Activities >VIGL
Vigil: Sanofi Will Purchase 537,634 of Company's Series A Non-Voting Preferred Shares >VIGL
Vigil: Sanofi Will Purchase 537,634 of Company's Series A Non-Voting Preferred Shares >VIGL